Decibel Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Decibel Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2023.
  • Decibel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $1.37M, a 62.3% increase year-over-year.
  • Decibel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $3.86M, a 24.8% increase year-over-year.
  • Decibel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.2M, a 13.6% increase from 2021.
  • Decibel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.82M, a 0.11% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $3.86M $1.37M +$527K +62.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $3.34M $977K +$135K +16% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $3.2M $636K +$265K +71.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $2.94M $876K -$160K -15.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $3.1M $846K +$82K +10.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $3.01M $842K +$196K +30.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.82M $371K -$1.85M -83.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $4.67M $1.04M +$851K +460% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $3.82M $764K +$585K +327% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $3.24M $646K +$421K +187% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.81M $2.23M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 $185K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $179K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $225K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.